Rankings
▼
Calendar
JSPR FY 2024 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
JSPR
Jasper Therapeutics, Inc.
$23M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$76M
Net Income
-$71M
EPS (Diluted)
$-4.89
Cash Flow
Operating Cash Flow
-$63M
Free Cash Flow
-$63M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$80M
Total Liabilities
$18M
Stockholders' Equity
$62M
Cash & Equivalents
$72M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$76M
-$69M
-10.7%
Net Income
-$71M
-$64M
-10.6%
← Q4 2023
All Quarters
Q1 2024 →